FailedFiled Jan 2, 2026
Sponsor: Melanie Stinnett
Latest Action
Placed Back on Formal Perfection Calendar (H)
May 7, 2026
Summary
The Hope for Missouri Patients Act adds new statutes that let qualified patients request one‑of‑a‑kind experimental drugs, biologics, or devices based on their genetic profile. It defines who can provide these treatments, the consent process, and makes clear that insurers or the state are not required to pay for them. The bill failed to pass.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 2643 changes status, plus AI-powered summaries and stage predictions.
Sign up free